 This year at the Vail Scientific Summit, it focuses on clinical and translational application of basic science research to helping improve care in the biologic realm for our patients. So it's very exciting because the data at more than almost 800 new articles a year being published in this field is getting to the point where we're really fine tuning on how to help patients with biologics. Some of the exciting things we're working on is how to really customize the biologic for you, to customize it for your injury, to customize it based on where you are after your injury and to customize it even just based on how the components were finding in your blood to help match that up better and just make a better injection that works better for your injury. Being in the clinic really provides a unique insight into what our patients want. They want to be active, they want to maintain health, they want to maintain the health of their joints, their muscles, their tendons, the rotator cuff, the knee, the hip with minimal intervention. Using their own biologics is I think going to be a perfect solution for that. We're not all the way there yet, but we're making significant progress to really help patients improve after injury. What's interesting about some of the research that's not only out of our facility, but out of other facilities is how well biologics work in the right indicated patient. The surprising part of it is it's better than what we've done before. PRP for early arthritis of the knee is much better than the gel injection, the chicken comb injection. PRP biologic is much better and that's been shown now in level one randomized trials. So that's very exciting for us because it's really tip of the iceberg, but we already know that it works. This meeting is very unique because under the direction of Dr. Johnny Huard, we're able to bring the best basic science researchers, translational researchers, and the best clinical minds together all in one room. That really doesn't happen in orthopedics. It's either clinical, surgical, non-operative, or maybe basic science, but here we're able to put it all together in a very specific targeted area that's very exciting biologics.